Effects of adrenaline in vivo on protein synthesis and sensitivity to ischemia of the perfused rat heart. 1977

B J Källfelt, and A P Waldenström, and A C Hjalmarson

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine

Related Publications

B J Källfelt, and A P Waldenström, and A C Hjalmarson
May 1976, Circulation research,
B J Källfelt, and A P Waldenström, and A C Hjalmarson
October 1976, Journal of molecular and cellular cardiology,
B J Källfelt, and A P Waldenström, and A C Hjalmarson
January 1985, Clinical and experimental pharmacology & physiology,
B J Källfelt, and A P Waldenström, and A C Hjalmarson
May 1992, Archives of biochemistry and biophysics,
B J Källfelt, and A P Waldenström, and A C Hjalmarson
September 1972, The Biochemical journal,
B J Källfelt, and A P Waldenström, and A C Hjalmarson
January 1988, Biochemistry and cell biology = Biochimie et biologie cellulaire,
B J Källfelt, and A P Waldenström, and A C Hjalmarson
April 1989, The Biochemical journal,
B J Källfelt, and A P Waldenström, and A C Hjalmarson
February 1983, Cardiovascular research,
B J Källfelt, and A P Waldenström, and A C Hjalmarson
September 1961, The Journal of physiology,
B J Källfelt, and A P Waldenström, and A C Hjalmarson
July 1979, Journal of molecular and cellular cardiology,
Copied contents to your clipboard!